Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimizide M SR 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Panvik Pharmaceuticals

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimizide M SR 2mg/500mg Tablet

Glimizide M SR 2mg/500mg tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This medication helps regulate blood sugar. Administer this medicine with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood glucose response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, incorporating a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential preventative measures. Alcohol consumption elevates hypoglycemia risk and should be minimized. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Uses of Glimizide M SR 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimizide M SR 2mg/500mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimizide M SR 2mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Glimizide M SR 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimizide M SR 2mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. This Glimizide M SR 2mg/500mg tablet should be administered with a meal.

How Glimizide M SR 2mg/500mg Tablet works:

Glimepiride/Metformin 2mg/500mg tablets (e.g., Glimizide M SR) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreased hepatic glucose output, reduced intestinal glucose uptake, and enhanced insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimizide M SR 2mg/500mg tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimizide M SR 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Glyburide modified-release 2mg/500mg tablets are contraindicated during lactation. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimizide M SR 2mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glimizide M SR 2mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is unsuitable for patients exhibiting severe hepatic dysfunction.

What if you forget to take Glimizide M SR 2mg/500mg Tablet :

Should you forget a Glimizide M SR 2mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimizide M SR 2mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimizide M SR 2mg/500mg Tablet

Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimizide M SR 2mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue use and seek immediate medical attention.
Glimizide M SR 2mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimizide M SR 2mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glimizide M SR 2mg/500mg Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological symptoms such as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimizide M SR 2mg/500mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases if you miss meals, drink alcohol, overexert yourself, or take other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimizide M SR 2mg/500mg tablets with alcohol is unsafe. Alcohol can exacerbate the medication's blood sugar-lowering effect, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glimizide M SR 2mg/500mg ...
37
MRP 45
17% off